Two-dimensional transthoracic echocardiographic demonstration of reduction in fibrin content in purulent pericarditis following intrapericardial fibrinolytic agent administration. 2022

Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
Department of Medicine, Conemaugh Memorial Medical Center/Temple University, Johnstown, Pennsylvania, USA.

We describe an adult patient who presented with purulent pericarditis (PP) in whom two-dimensional transthoracic echocardiography demonstrated a marked decrease in the area of the right ventricular (RV) wall together with the overlying fibrin following intrapericardial administration of a fibrinolytic agent. Documentation of this decrease by measurements performed and illustrated on two-dimensional images has not been reported previously in an adult patient with PP, to the best of our knowledge.

UI MeSH Term Description Entries
D010493 Pericarditis Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS. Pleuropericarditis
D010494 Pericarditis, Constrictive Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS. Constrictive Pericarditis,Pick's Disease of Heart,Pick Disease of Heart,Constrictive Pericarditides,Heart Pick's Disease,Pericarditides, Constrictive,Pick Disease, Heart,Picks Disease, Heart
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
August 1987, American heart journal,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
September 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
February 2023, Cureus,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
December 2004, Herz,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
March 1999, Archives of disease in childhood,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
May 2001, Intensive care medicine,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
December 2015, International journal of emergency medicine,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
September 2023, Circulation. Cardiovascular imaging,
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
April 2011, Critical care (London, England),
Mahmoud Abdelsalam, and Cyril Nathanial, and Zeyad Elmarzouky, and Subash Dulal, and Usama Habib, and Maram Ahmed, and Amir Ashiq, and Navin Nanda
November 1984, Chest,
Copied contents to your clipboard!